News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,168 Results
Type
Article (13764)
Company Profile (264)
Press Release (243140)
Section
Business (79222)
Career Advice (147)
Deals (13171)
Drug Delivery (29)
Drug Development (50209)
Employer Resources (31)
FDA (5647)
Job Trends (5104)
News (143757)
Policy (10015)
Tag
Academia (902)
Africa (145)
Allergies (30)
Alliances (21420)
Alzheimer's disease (693)
Antibody-drug conjugate (ADC) (33)
Approvals (5617)
Arizona (39)
Artificial intelligence (40)
Asia (16691)
Australia (2796)
Bankruptcy (96)
Best Places to Work (4384)
Biotechnology (221)
Breast cancer (36)
C2C Services and Suppliers (10611)
California (1380)
Canada (539)
Cancer (382)
Career advice (128)
CAR-T (36)
Cell therapy (111)
China (102)
Clinical research (39228)
Collaboration (118)
Colorado (47)
Compensation (57)
Connecticut (48)
COVID-19 (989)
Cystic fibrosis (61)
Data (335)
Diabetes (47)
Diagnostics (1168)
Earnings (28376)
Europe (35826)
Events (45970)
Executive appointments (115)
FDA (5808)
Florida (144)
Funding (123)
Gene editing (32)
Gene therapy (91)
GLP-1 (268)
Government (1059)
Healthcare (6510)
Hotbed/Location (184119)
Illinois (87)
Indiana (45)
Infectious disease (1004)
Inflammatory bowel disease (80)
IPO (7146)
Job creations (857)
Job search strategy (124)
Kansas (52)
Layoffs (178)
Legal (1370)
Lung cancer (78)
Manufacturing (44)
Maryland (216)
Massachusetts (1131)
Medical device (2525)
Medtech (2526)
Mergers & acquisitions (6057)
Metabolic disorders (157)
Michigan (39)
Minnesota (71)
Neuroscience (829)
New Jersey (368)
New York (439)
NextGen Class of 2024 (1978)
Non-profit (838)
North Carolina (347)
Northern California (600)
Obesity (90)
Ohio (66)
Opinion (87)
Parkinson's disease (45)
Patents (37)
Pennsylvania (306)
People (24768)
Pharmaceutical (42)
Phase I (13763)
Phase II (18236)
Phase III (11606)
Pipeline (95)
Postmarket research (845)
Preclinical (5788)
Radiopharmaceuticals (199)
Rare diseases (116)
Real estate (1406)
Regulatory (8071)
Research institute (929)
South America (207)
Southern California (572)
Startups (1963)
Texas (130)
United States (5232)
Vaccines (141)
Washington State (164)
Weight loss (63)
Date
Last 7 days (387)
Last 30 days (1499)
Last 365 days (21139)
2024 (15859)
2023 (22413)
2022 (26823)
2021 (27806)
2020 (23362)
2019 (16231)
2018 (11741)
2017 (13751)
2016 (11844)
2015 (14352)
2014 (10394)
2013 (7484)
2012 (7532)
2011 (7617)
2010 (7428)
257,168 Results for "hoth therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.
May 1, 2024
·
1 min read
Press Releases
Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer’s Drug HT-ALZ
September 17, 2024
·
5 min read
Pharm Country
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Hoth Therapeutics, Inc., a patient focused biopharmaceutical company, announced the entry into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia.
June 10, 2024
·
2 min read
Pharm Country
Hoth Therapeutics’ Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its subsidiary, Merveille.ai, in the field of obesity treatment.
March 27, 2024
·
4 min read
Drug Development
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer’s Disease Pre-Clinical Treatment with HT-ALZ
Hoth Therapeutics, Inc. (NASDAQ: HOTH), is pleased to unveil positive pre-clinical research showcasing the potential of HT-ALZ, an innovative Alzheimer’s disease therapeutic.
March 19, 2024
·
5 min read
Business
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Hoth Therapeutics, Inc. today announced that it will continue its work with Venable, LLP to develop and protect its intellectual property.
February 29, 2024
·
4 min read
Drug Development
Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial
September 5, 2024
·
4 min read
Press Releases
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
August 15, 2024
·
5 min read
Business
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Hoth Therapeutics, Inc. announced today that it has completed bioanalytical method development under its prior agreement with Altasciences and plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth’s sponsored scientific research conducted at NC State University.
February 26, 2024
·
4 min read
Press Releases
Hoth Therapeutics Expands Clinical Trial for Cancer Patients
July 16, 2024
·
4 min read
1 of 25,717
Next
